Skip Nav Destination
Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)
Issue Archive
October 30 2014
In this Issue
Table of Contents
EDITORIAL
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
Hematopoiesis and Stem Cells
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1
Yiran Guo,Melissa Kartawinata,Jiankang Li,Hilda A. Pickett,Juliana Teo,Tatjana Kilo,Pasquale M. Barbaro,Brendan Keating,Yulan Chen,Lifeng Tian,Ahmad Al-Odaib,Roger R. Reddel,John Christodoulou,Xun Xu,Hakon Hakonarson,Tracy M. Bryan
REVIEW SERIES
REVIEW SERIES
REVIEW SERIES
REVIEW SERIES
REVIEW SERIES
CLINICAL TRIALS AND OBSERVATIONS
Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution
Clinical Trials & Observations
Brief Report
Phillip Scheinberg,Danielle Townsley,Bogdan Dumitriu,Priscila Scheinberg,Barbara Weinstein,Maithili Daphtary,Olga Rios,Colin O. Wu,Neal S. Young
IMMUNOBIOLOGY
MYELOID NEOPLASIA
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts
Maria Krevvata,Barbara C. Silva,John S. Manavalan,Marta Galan-Diez,Aruna Kode,Brya Grace Matthews,David Park,Chiyuan A. Zhang,Naomi Galili,Thomas L. Nickolas,David W. Dempster,William Dougall,Julie Teruya-Feldstein,Aris N. Economides,Ivo Kalajzic,Azra Raza,Ellin Berman,Siddhartha Mukherjee,Govind Bhagat,Stavroula Kousteni
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia
Sylvain Audia,Marzia Rossato,Kim Santegoets,Sanne Spijkers,Catharina Wichers,Cornelis Bekker,Andries Bloem,Louis Boon,Thijs Flinsenberg,Ewoud Compeer,Theo van den Broek,Olivier Facy,Pablo Ortega-Deballon,Sabine Berthier,Vanessa Leguy-Seguin,Laurent Martin,Marion Ciudad,Maxime Samson,Malika Trad,Bernard Lorcerie,Nona Janikashvili,Philippe Saas,Bernard Bonnotte,Timothy R. D. J. Radstake
RED CELLS, IRON, AND ERYTHROPOIESIS
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)
Brief Report
Pranesh K. Chakraborty,Klaus Schmitz-Abe,Erin K. Kennedy,Hapsatou Mamady,Turaya Naas,Danielle Durie,Dean R. Campagna,Ashley Lau,Anoop K. Sendamarai,Daniel H. Wiseman,Alison May,Stephen Jolles,Philip Connor,Colin Powell,Matthew M. Heeney,Patricia-Jane Giardina,Robert J. Klaassen,Caroline Kannengiesser,Isabelle Thuret,Alexis A. Thompson,Laura Marques,Stephen Hughes,Denise K. Bonney,Sylvia S. Bottomley,Robert F. Wynn,Ronald M. Laxer,Caterina P. Minniti,John Moppett,Victoria Bordon,Michael Geraghty,Paul B. M. Joyce,Kyriacos Markianos,Adam D. Rudner,Martin Holcik,Mark D. Fleming
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
BLOOD WORK
ERRATA
-
Cover Image
Cover Image
Vα24-invariant natural killer T cells engineered to express chimeric antigen receptor against the GD2 ganglioside effectively localize to the tumor site and kill tumor cells in a humanized mouse model of neuroblastoma. See the article by Heczey et al on page 2824.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals